DJ Biogen Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slid 1.15% to $250.48 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.35% to 7,592.40 and Dow Jones Industrial Average falling 0.36% to 52,297.09.
Biogen Inc. closed 4.03% below its 52-week high of $261.00, which the company achieved on November 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.11% to $283.52, Pfizer Inc. $(PFE)$ fell 2.11% to $28.83, and AbbVie Inc. $(ABBV)$ fell 0.18% to $294.45.
Trading volume (791,799) remained 385,056 below its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 12, 2026.
Comments